Soreide Law Group has been contacted by clients who purchased PhaseRx, Inc. (PZRXQ) and experienced significant stock losses through the sale of the stock brokers at Laidlaw and Company. Laidlaw is listed on their website as the “Book Runner” from the May 2016 offering. Securities that are newly issued are typically more volatile than the older […]

Soreide Law Group has been receiving calls from our clients who purchased MabVax Therapeutics Holdings, Inc. (MBVX) and experienced significant stock losses.  Not only were the brokers from Laidlaw and Company offering this stock, but Laidlaw also served as the “Sole Placement Agent” for the offering. Securities that are newly issued are typically more volatile […]